Skip to Main Content

As concerns persist over the safety of medicines made overseas, the Food and Drug Administration recently touted data showing the number of facilities inspected in foreign countries had increased 20% over the most recent five-year period.

Specifically, the agency inspected 993 foreign plants in fiscal year 2014 compared with 1,245 in fiscal year 2018. At the same time, though, the FDA inspected fewer domestic facilities during that period — 1,869 versus 1,662, which amounts to a 12.5% drop.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!